In vitro fertilization (IVF) is one of the most successful assisted reproductive techniques used for couples who are unable to conceive naturally. Preimplantation Genetic Testing (PGT) is an advanced technique within the IVF process that allows for the genetic screening of embryos. This method offers significant advantages for couples who are carriers of genetic disorders, have experienced recurrent miscarriages, advanced maternal age, or previous unsuccessful IVF attempts. The treatment begins with stimulating the woman’s ovaries using medication, followed by the retrieval of the developed eggs. These eggs are then fertilized with sperm in a laboratory setting to create embryos. After a few days of development, a biopsy is performed on the embryos to collect samples for genetic analysis. Through PGT, chromosomal abnormalities, single-gene disorders, or structural genetic defects in the embryos can be identified. Embryos determined to be healthy are selected and transferred to the uterus in a way that maximizes the chance of pregnancy. This method not only increases the success rate of conception but also minimizes the risk of passing on genetic diseases, enhancing the chance of delivering a healthy baby. In conclusion, IVF treatment supported by PGT reduces genetic risks, paves the way for healthy pregnancies, and increases success rates, bringing families one step closer to realizing their dream of having a child.